Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

NCT00795457 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Astrocytoma
Oligo-Astrocytoma
Glioma

Interventions

BIOLOGICAL: GAA/TT-peptide vaccine and poly-ICLC
BIOLOGICAL: GAA/TT-peptide vaccine and poly-ICLC

Sponsor

Ian F. Pollack, M.D.

Collaborators

[object Object]
[object Object]